iiinova — where your digital self keeps evolving

D-SOLVE Consortium @d-solve-consortium.bsky.social · 25/06/2026

Landmark D-SOLVE publication: Large real-world cohort shows chronic hepatitis D is often advanced & continues to progress; viral activity drives outcomes. gut.bmj.com/content/earl... Image: Kamal et al., Gut 2026 (CC BY-NC) #D-SOLVE #HDV #HaDEA #EUHealth

Graphical abstract from Kamal et al., Gut 2026, doi:10.1136/gutjnl-2025-336234 (CC BY‑NC)

000

D-SOLVE Consortium @d-solve-consortium.bsky.social · 26/01/2026

🔴 Live now: Prof. Dr. Maike Hofmann (University Hospital Freiburg) on “T cell exhaustion and beyond: lessons from chronic viral hepatitis” – part of our translational seminar series. Join 👉 msteams.link/DGTP #TCells #Hepatitis #HaDEA #EUHealth @ec.europa.eu

000

D-SOLVE Consortium @d-solve-consortium.bsky.social · 08/12/2025

🎙️ Live now! Prof. Eui-Cheol Shin (KAIST, Korea) is presenting “Cytokine-induced bystander CD8+ T cell activation and its regulation in viral hepatitis” – part of our Translational Seminar Series. Join the discussion live 👉 msteams.link/DGTP #HepatitisD #D-SOLVE #HaDEA #EUHealth

010

D-SOLVE Consortium @d-solve-consortium.bsky.social · 27/10/2025

🔴 Tune in now: Dr. Sabela Lens (Hospital Clínic de Barcelona) is sharing insights on “Understanding Hepatitis B/Delta: ongoing efforts” – part of our translational seminar series. Join 👉 msteams.link/DGTP #Hepatitis #D-SOLVE #HaDEA #EUHealth @ec.europa.eu

020

D-SOLVE Consortium @d-solve-consortium.bsky.social · 17/09/2025

🧬 D-SOLVE lecture via MS Teams: Hepatitis D in Mongolia – Screening Study among Mongol Migrants in Sweden 👤 Speakers from Karolinska/Sweden & Mongolia 🗓️ Tue, 23 Sept | 🕐 12:45–13:30 CET 🔗 bit.ly/46oxjnH 🔑 ID: 368 532 223 585 | PW: dq64Nb9t #DSOLVE #HepatitisD #PublicHealth

010

D-SOLVE Consortium @d-solve-consortium.bsky.social · 02/09/2025

🧬 Join the HBV Community Forum & Int. HBV Meeting in Berlin (Sept 8–12), on-site or online! 🎤 Science meets community – Hepatitis B & D! D-SOLVE’s Heiner Wedemeyer & Helenie Kefalakes will be there. 👉 www.hbvmeeting.org #HBVForum2025 #HepatitisB #HepatitisD

Flyer International HBV Meeting 8-12 Sept 2025 Berlin

000

D-SOLVE Consortium @d-solve-consortium.bsky.social · 09/05/2025

📢 EASL Congress: E. Degasperi from our #D-SOLVE Consortium presents results from a large real-life cohort on clinical outcomes of chronic hepatitis D patients. Rates of cirrhosis & liver-related events were lower than expected. ALT, age & HDV RNA were key determinants. #EASL2025 #HepatitisResearch

Elisabetta Degasperi from the D-SOLVE consortium presents at EASL congress 2025 in Amsterdam

020

D-SOLVE Consortium @d-solve-consortium.bsky.social · 13/02/2025

Researchers from Hannover Medical School (MHH) identified a marker on NK cells showing how Bulevirtid alleviates liver inflammation in Hepatitis D. Bulevirtid blocks viral entry and reduces inflammation, even with high viral load, by activating the immune marker TIGIT. More info: bit.ly/40VPqi3.

Have discovered how the drug Bulevirtid alleviates liver inflammation in Hepatitis D infections: (from left) Professor Dr. Heiner Wedemeyer, Po-Chun Chen, and Dr. Norman Woller. Copyright: Karin Kaiser / MHH

042

D-SOLVE Consortium @d-solve-consortium.bsky.social · 07/02/2025

Welcome to the official Bluesky channel of the D‑SOLVE Consortium. We look forward to engaging with the scientific community and stakeholders committed to improving liver health worldwide. Stay tuned for updates and also check our website (www.d-solve-consortium.eu) for more information.

picture of the team at a consortium meeting in 2024 in Milan, Italy

131